Aduhelm’s makers Biogen and its partner Eisai are taking a page right out of a classic marketing playbook: Run an educational campaign directed at the consumer, one who is already worried about whether those lost keys or a hard-to-recall name is a sign of something grave.
Source: https://www.bemidjipioneer.com
Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign
More from PuposkyMore posts in Puposky »
- Tracy Dill reflects on 9-year tenure as Bemidji State athletic director
- Bemidji State offers second round of full-tuition math scholarships
- After Moorhead family deaths, Klobuchar and Hoeven push agency on carbon monoxide protection
- Minnesota COVID risk records shattered once again; more than 19% of tests positive
- At the Capitol, Democrats require employee COVID-19 vaccine or test, Republicans await court guidance
Be First to Comment